Dalian BIO-CHEM Company Limited: history, ownership, mission, how it works & makes money

Dalian BIO-CHEM Company Limited reads like a growth story in numbers: founded in 2003 as an industrial fungicide specialist, the Shanghai-listed firm (ticker 603360) posted CNY 1.31 billion in revenue for 2024 - a 23.09% year‑over‑year rise - with net income of CNY 345 million (up 5.14% YoY), while expanding headcount to 953 employees (a 35.95% increase) and trimming carbon emissions by 15% over three years; its strategic shift includes a 46.7% stake in Suzhou Xinhuilian Semiconductor Technology (acquired October 2024) that helped deliver a semiconductor-quarter revenue of CNY 260 million (a 389.39% YoY jump), and the company backs R&D aggressively - roughly 20% of revenue (~CNY 150 million) - alongside shareholder-friendly moves like repurchasing 267,900 shares for CNY 5.41 million and maintaining a market capitalization of CNY 21.41 billion (as of December 16, 2025) with a CNY 0.43 annual dividend (≈1.32% yield), all under an ownership structure of 700.86 million shares outstanding with insiders holding 30.61% and institutions 0.74%, positioning the firm at the intersection of chemical manufacturing, semiconductor diversification and sustainability-driven innovation.

Dalian BIO-CHEM Company Limited (603360.SS): Intro

• Founded in 2003 to research, develop, produce and sell industrial fungicides for domestic and international markets.
• Scaled through product-line expansion and export growth across Asia, Europe and other regions over the 2000s-2010s.
• October 2024: strategic diversification into semiconductors via acquisition of a 46.7% stake in Suzhou Xinhuilian Semiconductor Technology.
• July 2025: returned capital to the market by repurchasing 267,900 shares (~0.04% of total share capital) for CNY 5.41 million.

• Publicly traded on the SSE; free float and institutional investor base determine market liquidity and price discovery.
• Share repurchase in July 2025 signals board-level confidence in balance sheet and EPS support.
• Strategic minority acquisition in semiconductors introduces cross-sector exposure without full consolidation risk.

• Mission: develop high-performance industrial fungicides and related chemical solutions while expanding technology-driven revenue streams.
• Strategic pillars: product R&D, regulatory compliance, export market penetration, and selective diversification (semiconductor investment).

• R&D: in-house formulation and process development focused on fungicide efficacy, stability and manufacturing scalability.
• Manufacturing: industrial-scale chemical production facilities adhering to environmental and safety standards.
• Sales & distribution: domestic sales force, distributor networks and export channels to agricultural and industrial customers.
• After-sales & regulatory: product registration, technical support and compliance with local/overseas chemical regulations.

• Product sales: primary revenue from industrial fungicide formulations sold to industrial and agricultural customers.
• Licensing & technical services: fees from formulation licensing, technical consulting and registration support.
• Export sales: incremental revenue from international customers-contributed to the 23.09% revenue growth in 2024.
• Investment income & strategic holdings: dividends/returns and potential synergies from the 46.7% semiconductor stake, plus occasional treasury actions (share buybacks).

• Top-line growth: 2024 revenue reached CNY 1.31 billion, up 23.09% YoY driven by volume and export expansion.
• Profitability: 2024 net income of CNY 345 million (+5.14% YoY) reflects margin pressure from costs and investment while still delivering positive net earnings.
• Operational scale: headcount rose to 953 by end-2024 (up 35.95% YoY), supporting production and R&D ramp-up.
• Capital deployment: targeted M&A (semiconductor stake) and buybacks (Jul 2025) indicate a mix of growth and shareholder-value actions.

• Regulatory risk: chemical product registrations and environmental compliance can affect time-to-market and costs.
• Commodity / input cost volatility: feedstock price swings can compress margins.
• Diversification execution: semiconductor stake exposure adds sectoral risk outside core competencies.
• Market competition: domestic and global agrochemical players competing on price, efficacy and service.

Dalian BIO-CHEM Company Limited (603360.SS): History

• Founded with a focus on biochemical intermediates and specialty chemicals for pharmaceuticals and agrochemicals.
• Transitioned to public markets to fund capacity expansion and R&D, listing on the Shanghai Stock Exchange under 603360.SS.
• Maintained founder-led management, supporting long-term strategy and operational continuity.

• Founder-led: Hailong Liu as the largest shareholder ensures concentrated control and strategic continuity.
• Public float: Approximate free float complemented by modest institutional participation (0.74% as of Jul 5, 2025).
• Share buybacks: Ongoing capital-return signal - July 2025 repurchase of 267,900 shares for CNY 5.41 million (~0.04% of capital).

• Deliver high-quality biochemical intermediates and specialty chemicals to pharmaceutical, agrochemical and industrial clients.
• Invest in R&D and production efficiency to scale margins and expand into higher-value product segments.

• Manufacturing: Large-scale chemical synthesis and downstream processing for intermediates sold to drug makers and industrial producers.
• Product mix: Revenue driven by a mix of contract orders, long-term supply agreements, and spot sales of specialty intermediates.
• R&D and premium products: Higher-margin proprietary intermediates and formulations produced from in-house R&D deliver margin uplift.
• Vertical integration: Control over upstream feedstocks and downstream processing improves cost structure and reliability for customers.

Dalian BIO-CHEM Company Limited (603360.SS): Ownership Structure

Dalian BIO-CHEM Company Limited (603360.SS) focuses on researching, developing, producing, and selling industrial fungicides and amino-acid-based preservatives for domestic and international markets. The company emphasizes innovation, quality, sustainability, global expansion, customer-centric OEM/ODM services, and adherence to international standards such as ISO 14001 and ISO 9001.

• Mission: Provide high-quality industrial fungicides and amino-acid solutions to safeguard products across industries while driving innovation and sustainable practices.
• Core values: Innovation, quality, sustainability, customer focus, integrity, transparency.
• R&D commitment: ~20% of annual revenue reinvested into research and development to expand product lines and new amino acid applications.
• Sustainability achievements: 15% reduction in carbon emissions over the past three years via energy-efficiency upgrades and waste reduction.
• Standards & compliance: Certified to ISO 14001 (Environmental Management) and ISO 9001 (Quality Management).

Ownership breakdown (approximate, latest disclosed):

How it works & makes money:

• Product portfolio: Industrial fungicides, amino-acid-based preservatives, specialty biochemical intermediates sold under branded and OEM/ODM arrangements.
• Revenue streams:
  • Direct product sales (domestic & export)
  • OEM/ODM manufacturing contracts and private-label supply
  • Technical service agreements and licensing of formulations
• Profit drivers: High-margin specialty formulations, recurring OEM contracts, and R&D-driven product upgrades that command price premia.
• Geographic footprint: Active markets in Europe, the Americas, and across Asia with growing export mix (~40% of revenue from overseas markets in recent years).

Customer & partner focus:

• OEM/ODM capabilities tailored to packaging, formulation, and private-label requirements.
• Technical support teams for formulation adaptation and regulatory compliance across jurisdictions.
• Long-term supply agreements with distributors and industrial customers to stabilize cash flows.

Further reading: Exploring Dalian BIO-CHEM Company Limited Investor Profile: Who's Buying and Why?

Dalian BIO-CHEM Company Limited (603360.SS): Mission and Values

• Vertical integration: in-house R&D, pilot development, large-scale production, quality control, and direct sales channels enable tight cost and quality control across the value chain.
• Product portfolio: industrial isothiazolinone fungicides and biocides - CMIT/MIT, MIT, OIT, DCOIT, BIT series - formulated for coatings, paints, wood preservation, cooling water systems, adhesives, and other industrial applications.
• OEM/ODM services: collaborative product development and private-label manufacturing to meet bespoke customer specifications and regulatory requirements, strengthening long-term client relationships.
• Organizational structure: centralized management with clear executive responsibilities to accelerate decision-making and strategic deployments.

• CEO: Hailong Liu
• Financial Director: Xi Liang Wang
• Deputy General Manager: Jie Yang

• Semiconductor move: in October 2024, the company acquired a 46.7% stake in Suzhou Xinhuilian Semiconductor Technology, diversifying revenue sources beyond specialty biocides and positioning the company in higher-margin, technology-driven markets.
• Market approach: leveraging chemistry and process expertise to offer antimicrobial solutions for demanding semiconductor wet processes and related specialty chemical needs.

• R&D intensity: approximately 20% of revenue is allocated to R&D; in the latest fiscal year this equated to roughly CNY 150 million in R&D spending.
• Capabilities: formulation chemistry, toxicology screening, application-specific testing (e.g., coating compatibility, corrosion inhibition), and scale-up engineering for production transfer.

• Direct product sales: core revenue from sales of isothiazolinone fungicides and related biocide formulations to industrial OEMs, paint and coatings manufacturers, water treatment operators, and other industrial end-users.
• OEM/ODM contracts: margin-bearing customized manufacturing and formulation services for strategic customers under private-label agreements.
• Investment income and equity returns: dividend and capital appreciation potential from the 46.7% stake in Suzhou Xinhuilian Semiconductor Technology and related strategic partnerships.
• After-sales and technical services: recurring revenue through technical support, compliance documentation, and supply-chain integration services.

Dalian BIO-CHEM Company Limited (603360.SS): How It Works

• Primary products: industrial fungicides sold to agriculture, industrial processors, and specialty chemical distributors.
• Semiconductor chemicals: high-purity reagents and process chemicals for semiconductor fabs and specialty material suppliers.
• OEM/ODM services: tailored synthesis, formulation, private-label manufacturing and technical support for third-party clients.
• Distribution and export: domestic sales channels plus export relationships for key formulations.

• R&D and formulation-internal teams develop active ingredients and formulations, enabling product differentiation and premium pricing.
• Scale manufacturing-multi-line chemical production plants support both in-house brands and contract manufacturing volumes.
• Quality & compliance-certified QA/QC and process controls for agricultural and semiconductor-grade products (purity, particle size, contamination control).
• Sales channels-direct sales to large industrial customers, distributors for broader market reach, and long-term supply contracts for semiconductor customers.

• Semiconductor expansion: semiconductor business reported quarterly revenue of CNY 260 million, a year-on-year increase of 389.39% for that quarter-reflecting rapid uptake of high-margin specialty chemicals in that sector.
• OEM/ODM: customized solutions act as both a margin-enhancer and a volume stabilizer by locking in multi-year client engagements.
• Fungicide legacy: industrial fungicides remain the revenue backbone, providing steady cash flow while new segments scale.

• Publicly listed on Shanghai Stock Exchange (603360.SS) with a market cap of CNY 21.41 billion (16 Dec 2025).
• Maintains shareholder returns via an annual cash dividend (CNY 0.43/share; ~1.32% yield), indicating ongoing profitability and capital allocation to investors.
• Ownership includes institutional investors and strategic stakeholders supporting both agrochemical and advanced-materials business lines.

• Customer inquiry and specification → technical vetting and sample formulation.
• Batch design and scale-up in R&D → pilot production and quality validation.
• Full-scale manufacturing with QA release → packaging and logistics (domestic/export compliance).
• After-sales technical support, lifecycle management, and repeat contracts (OEM/ODM clients often form long-term relationships).

• Industrial fungicides provide stable revenues and cash generation; semiconductor chemicals contribute faster growth and higher margins as adoption increases.
• OEM/ODM creates stickiness with customers and diversifies revenue beyond branded products.
• Financials (TTM revenue CNY 1.47 billion; net income CNY 216.03 million) show operational profitability enabling reinvestment in R&D and capacity expansion.

Dalian BIO-CHEM Company Limited (603360.SS): How It Makes Money

• Core product lines: industrial fungicides and agrochemicals (domestic + export markets)
• Emerging business: semiconductor-grade chemicals and materials targeting fabs and electronic manufacturers
• Technology & services: custom synthesis, R&D partnerships, and licensing of proprietary formulations
• Growth levers: M&A, capacity expansion, and entry into higher-margin specialty chemical niches

• Competitive position: strong share in industrial fungicides with a broad product portfolio and established distribution channels in both domestic and international markets.
• R&D focus: heavy reinvestment (~20% of sales) fuels pipeline development for next-generation crop protection agents and specialty semiconductor chemicals, supporting margin improvement potential.
• Sustainability & compliance: 15% cut in carbon emissions over three years improves regulatory positioning and buyer appeal in ESG-sensitive markets.
• Future outlook: semiconductor-chemicals push positions the company to capture rising demand from global chip manufacturing growth; strategic M&A and capacity builds aim to convert R&D into higher-margin sales.